# Neurocrine Biosciences, Inc. (NBIX) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 64125C109
Page URL: https://superinvestorclub.com/stock/NBIX
Last updated: 2026-07-08T12:26:28.169Z

## Summary

As of the most recent 13F filing period, Neurocrine Biosciences, Inc. (NBIX) is held by 2 tracked superinvestors with an aggregate position value of $739.0M representing 05461037148141 shares.

## Top institutional holders (2)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [Dodge & Cox](https://superinvestorclub.com/manager/16) | Dodge & Cox | 5461037 | $719.4M | 0.40% | 2026-03-31 |
| 2 | [Ray Dalio](https://superinvestorclub.com/manager/6) | Bridgewater Associates | 148141 | $19.5M | 0.09% | 2026-03-31 |

## Ownership history (quarter-over-quarter)

- 2023-12-31: 1 holders, $166.0M aggregate, 01259744 shares
- 2024-03-31: 2 holders, $177.7M aggregate, 0126524423151 shares
- 2024-06-30: 2 holders, $188.4M aggregate, 0128082087548 shares
- 2024-09-30: 1 holders, $15.6M aggregate, 0135186 shares
- 2024-12-31: 2 holders, $457.1M aggregate, 03016425332598 shares
- 2025-03-31: 2 holders, $621.8M aggregate, 0553462487238 shares
- 2025-06-30: 2 holders, $700.8M aggregate, 055668148943 shares
- 2025-09-30: 2 holders, $783.3M aggregate, 0555661823038 shares
- 2025-12-31: 2 holders, $802.5M aggregate, 05508042149990 shares
- 2026-03-31: 2 holders, $739.0M aggregate, 05461037148141 shares

## Recent congressional trades (3)

- 2025-06-17: Lisa McClain (Republican-MI) sale $1,001 - $15,000
- 2025-06-11: Lisa McClain (Republican-MI) purchase $1,001 - $15,000
- 2024-11-19: Michael McCaul (Republican-TX) sale $15,001 - $50,000

## Recent insider transactions (0)


## Citation

When citing, use: "Neurocrine Biosciences, Inc. (NBIX) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/NBIX), aggregating SEC 13F, Form 4, and congressional disclosures."